Cognitive effects of scopolamine in dementia
β Scribed by J. M. Rabey; M. Y. Neufeld; T. A. Treves; P. Sifris; A. D. Korczyn
- Publisher
- Springer
- Year
- 1996
- Tongue
- English
- Weight
- 609 KB
- Volume
- 103
- Category
- Article
- ISSN
- 1435-1463
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The eects of physostigmine on scopolamine-induced changes were investigated in a randomized, double-blind crossover study utilizing quantitative electroencephalogram (qEEG) and cognitive tasks. Ten healthy male volunteers received scopolamine 0 . 6 mg subcutaneously. After 90 min, single doses of ei
## Abstract The objective of this study was to investigate whether the Cambridge Cognitive Examination (CAMCOG), a widely used screening test for dementia, can be tailored to the individual patient with Computerized Adaptive Testing (CAT). CAT accomplishes this by only using items that are appropri
## Abstract There are theoretical grounds for believing that scopolamineβinduced cognitive deficit may be predictive of future cognitive decline. In the present study, 22 healthy elderly volunteers were reassessed 3 years after a scopolamine challenge. Although there was little overall change in me
## Abstract ## Background There is good evidence indicating that group Cognitive Stimulation Therapy (CST) leads to generalised cognitive benefits for people with dementia. However, little is known about whether some aspects of cognition might change more than others and why. ## Methods Cognitiv